Mutant HSP70 reverses autoimmune depigmentation in vitiligo

Science Translational Medicine

Volumn 5, Issue 174, 2013, Pages

  Mosenson, Jeffrey A ^a   Zloza, Andrew ^b,c   Nieland, John D ^d   Garrett Mayer, Elizabeth ^e   Eby, Jonathan M ^a   Huelsmann, Erica J ^b   Kumar, Previn ^f   Denman, Cecele J ^a   Lacek, Andrew T ^b   Kohlhapp, Frederick J ^g   Alamiri, Ahmad ^b   Hughes, Tasha ^b   Bines, Steven D ^b   Kaufman, Howard L ^b   Overbeck, Andreas ^h   Mehrotra, Shikhar ⁱ   Hernandez, Claudia ^j   Nishimura, Michael I ^c   Guevara Patino, Jose A ^c   Le Poole, I Caroline ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f ILLINOIS MATHEMATICS AND SCIENCE ACADEMY   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h Lumiderm   (Spain)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; MUTANT PROTEIN; PLASMID DNA; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; MELANOCYTE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; STRESS; T LYMPHOCYTE; TRANSGENIC MOUSE; VITILIGO;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; AUTOIMMUNITY; DENDRITIC CELLS; DISEASE PROGRESSION; GENETIC THERAPY; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPOPIGMENTATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MUTANT PROTEINS; PEPTIDES; PHENOTYPE; SKIN; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TRANSFECTION; VACCINATION; VITILIGO;

EID: 84875448409     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005127     Document Type: Article

References (45)

1. P. K. Das, R. M. van den Wijngaard, A. Wankowicz-Kalinska, I. C. Le Poole, A symbiotic concept of autoimmunity and tumour immunity: Lessons from vitiligo. Trends Immunol. 22, 130-136 (2001).
2. K. Cedercreutz, C. J. Denman, J. Klarquist, R. Vaitla, R. E. Boissy, W. Westerhof, C. Hernandez, I. C. Le Poole, Vitiligo etiology and treatment: Parameters derived from a patient survey. J. Dermatol. Nurs. Assoc. 2, 265-272 (2010).
3. R. Colucci, T. Lotti, S. Moretti, Vitiligo: An update on current pharmacotherapy and future directions. Expert Opin. Pharmacother. 13, 1885-1899 (2012).
4. Y. Teraki, K. Hitomi, Y. Sato, S. Izaki, Tacrolimus-induced rosacea-like dermatitis: A clinical analysis of 16 cases associated with tacrolimus ointment application. Dermatology 224, 309-314 (2012).
5. A. R. Hossani-Madani, R. M. Halder, Topical treatment and combination approaches for vitiligo: New insights, new developments. G. Ital. Dermatol. Venereol. 145, 57-78 (2010).
6. A. Fongers, A. Wolkerstorfer, L. Nieuweboer-Krobotova, P. Krawczyk, G. G. Tóth, J. P. van der Veen, Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: Effect of disease activity. Br. J. Dermatol. 161, 1105-1111 (2009).
7. + T cells to type-1-like is associated with melanocyte loss in human vitiligo. Lab. Invest. 83, 683-695 (2003).
8. K. Oyarbide-Valencia, J. G. van den Boorn, C. J. Denman, M. Li, J. M. Carlson, C. Hernandez, M. I. Nishimura, P. K. Das, R. M. Luiten, I. C. Le Poole, Therapeutic implications of autoimmune vitiligo T cells. Autoimmun. Rev. 5, 486-492 (2006).
9. T. M. Kroll, H. Bommiasamy, R. E. Boissy, C. Hernandez, B. J. Nickoloff, R. Mestril, I. Caroline Le Poole, 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cellmediated killing: Relevance to vitiligo. J. Invest. Dermatol. 124, 798-806 (2005).
10. J. A. Mosenson, A. Zloza, J. Klarquist, A. J. Barfuss, J. A. Guevara-Patino, I. C. Poole, HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res. 25, 88-98 (2012).
11. I. C. Le Poole, R. M. Luiten, Autoimmune etiology of generalized vitiligo. Curr. Dir. Autoimmun. 10, 227-243 (2008).
12. C. J. Denman, J. McCracken, V. Hariharan, J. Klarquist, K. Oyarbide-Valencia, J. A. Guevara-Patiño, I. C. Le Poole, HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J. Invest. Dermatol. 128, 2041-2048 (2008).
13. A. Asea, Mechanisms of HSP72 release. J. Biosci. 32, 579-584 (2007).
14. P. Srivastava, Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20, 395-425 (2002).
15. A. Asea,M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, S. K. Calderwood, Novel signal transduction pathway utilized by extracellular HSP70: Role of Toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034 (2002).
16. S. Basu, R. J. Binder, T. Ramalingam, P. K. Srivastava, CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14, 303-313 (2001).
17. T. Becker, F. U. Hartl, F. Wieland, CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158, 1277-1285 (2002).
18. Y. Wang, T. Whittall, E. McGowan, J. Younson, C. Kelly, L. A. Bergmeier, M. Singh, T. Lehner, Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J. Immunol. 174, 3306-3316 (2005).
19. B. Pulendran, H. Tang, T. L. Denning, Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 20, 61-67 (2008).
20. T. L. Denning, Y. C. Wang, S. R. Patel, I. R. Williams, B. Pulendran, Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8, 1086-1094 (2007).
21. + T cells. J. Exp. Med. 198, 569-580 (2003).
22. S. Mehrotra, A. A. Al-Khami, J. Klarquist, S. Husain, O. Naga, J. M. Eby, A. K. Murali, G. E. Lyons, M. Li, N. D. Spivey, H. Norell, T. Martins da Palma, G. Onicescu, C. M. Diaz-Montero, E. Garrett-Mayer, D. J. Cole, I. C. Le Poole, M. I. Nishimura, A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J. Immunol. 189, 1627-1638 (2012).
23. I. C. Le Poole, R. M. van den Wijngaard, W. Westerhof, P. K. Das, Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am. J. Pathol. 148, 1219-1228 (1996).
24. J. A. Guevara-Patiño, M. E. Engelhorn, M. J. Turk, C. Liu, F. Duan, G. Rizzuto, A. D. Cohen, T.Merghoub, J. D. Wolchok, A. N. Houghton, Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J. Clin. Invest. 116, 1382-1390 (2006).
25. + T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32, 67-78 (2010).
26. R. K. Gregg, L. Nichols, Y. Chen, B. Lu, V. H. Engelhard, Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J. Immunol. 184, 1909-1917 (2010).
27. D. W. O'Neill, N. Bhardwaj, in Current Protocols in Immunology (John Wiley & Sons Inc., New York, 2001).
28. + T cells at the perilesional site. Lab. Invest. 80, 1299-1309 (2000).
29. Y. Wang, C. G. Kelly, M. Singh, E. G. McGowan, A. S. Carrara, L. A. Bergmeier, T. Lehner, Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169, 2422-2429 (2002).
30. H. Zhang, W. Wang, Q. Li, W. Huang, Fusion protein of ATPase domain of Hsc70 with TRP2 acting as a tumor vaccine against B16 melanoma. Immunol. Lett. 105, 167-173 (2006).
31. B. Javid, P. A. MacAry, P. J. Lehner, Structure and function: Heat shock proteins and adaptive immunity. J. Immunol. 179, 2035-2040 (2007).
32. A. Germot, H. Philippe, Critical analysis of eukaryotic phylogeny: A case study based on the HSP70 family. J. Eukaryot. Microbiol. 46, 116-124 (1999).
33. E. Adams, W. J. Britton, A. Morgan, A. L. Goodsall, A. Basten, Identification of human T cell epitopes in the Mycobacterium leprae heat shock protein 70-kD antigen. Clin. Exp. Immunol. 94, 500-506 (1993).
34. T. B. H. Geijtenbeek, S. J. van Vliet, A. Engering, B. A. 't Hart, Y. van Kooyk, Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22, 33-54 (2004).
35. Y. Delneste, G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, P. Jeannin, Involvement of LOX-1 in dendritic cellmediated antigen cross-presentation. Immunity 17, 353-362 (2002).
36. S. Zitzler, A. Hellwig, F. U. Hartl, F. Wieland, P. Diestelkötter- Bachert, Distinct binding sites for the ATPase and substrate binding domain of human Hsp70 on the cell surface of antigen presenting cells. Mol. Immunol. 45, 3974-3983 (2008).
37. J. Kocsis, A. Veres, A. Vatay, J. Duba, I. Karádi, G. Fust, Z. Prohászka, Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease. Immunol. Invest. 31, 219-231 (2002).
38. H. Watabe, J. C. Valencia, K. Yasumoto, T. Kushimoto, H. Ando, J. Muller, W. D. Vieira, M. Mizoguch, E. Appella, V. J. Hearing, Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. J. Biol. Chem. 279, 7971-7981 (2004).
39. J. Diao, A. Mikhailova, M. Tang, H. Gu, J. Zhao, M. S. Cattral, Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells. Blood 119, 4919-4927 (2012).
40. M. Ioanno, T. Alissafi, I. Lazarisdis, G. Deraos, J. Matsoukas, A. Gravani, V. Mastorodemos, A. Plaitakis, A. Sharpe, D. Boumpas, P. Verginis, Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 188, 1136-1146 (2012).
41. R. Rezzonico, R. Chicheportiche, V. Imbert, J. M. Dayer, Engagement of CD11b and CD11c β2 integrin by antibodies or soluble CD23 induces IL-1β production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 95, 3868-3877 (2000).
42. A. Bolhassani, S. Safaiyan, S. Rafati, Improvement of different vaccine delivery systems for cancer therapy. Mol. Cancer 10, 3 (2011).
43. T. Murakami, Y. Sunada, Plasmid DNA gene therapy by electroporation: Principles and recent advances. Curr. Gene Ther. 11, 447-456 (2011).
44. I. C. Le Poole, R. M. van den Wijngaard, W. Westerhof, R. P. Dutrieux, P. K. Das, Presence or absence of melanocytes in vitiligo lesions: An immunohistochemical investigation. J. Invest. Dermatol. 100, 816-822 (1993).
45. D. H. Jones, K. Sakamoto, R. L. Vorce, B. H. Howard, DNA mutagenesis and recombination. Nature 344, 793-794 (1990).